skip to main content
Language:

Results 1 - 10 of 777  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
Material Type:
Article 		Add to e-Shelf

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice

Rossin, Raffaella ; Versteegen, Ron M ; Wu, Jeremy ; Khasanov, Alisher ; Wessels, H.J ; Steenbergen, E.J ; Hudson, Peter J ; Robillard, Marc S

Nature communications, 2018, Vol.9 (1), p.1484-1484 [Peer Reviewed Journal]

Full text available

Citations Cited by
2
Strategies and challenges for the next generation of antibody-drug conjugates
Strategies and challenges for the next generation of antibody-drug conjugates
Material Type:
Article 		Add to e-Shelf

Strategies and challenges for the next generation of antibody-drug conjugates

Beck, Alain ; Goetsch, Liliane ; Dumontet, Charles ; Corvaïa, Nathalie

Nature reviews. Drug discovery, 2017-05, Vol.16 (5), p.315-337 [Peer Reviewed Journal]

Full text available

Citations Cited by
3
Antibody Drug Conjugates for Cancer Therapy
Antibody Drug Conjugates for Cancer Therapy
Material Type:
Article 		Add to e-Shelf

Antibody Drug Conjugates for Cancer Therapy

Polakis, Paul Esbenshade, Timothy A

Pharmacological reviews, 2016-01, Vol.68 (1), p.3-19 [Peer Reviewed Journal]

Full text available

Citations Cited by
4
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Material Type:
Article 		Add to e-Shelf

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Connors, Joseph M ; Jurczak, Wojciech ; Straus, David J ; Ansell, Stephen M ; Kim, Won S ; Gallamini, Andrea ; Younes, Anas ; Alekseev, Sergey ; Illés, Árpád ; Picardi, Marco ; Lech-Maranda, Ewa ; Oki, Yasuhiro ; Feldman, Tatyana ; Smolewski, Piotr ; Savage, Kerry J ; Bartlett, Nancy L ; Walewski, Jan ; Chen, Robert ; Ramchandren, Radhakrishnan ; Zinzani, Pier L ; Cunningham, David ; Rosta, Andras ; Josephson, Neil C ; Song, Eric ; Sachs, Jessica ; Liu, Rachael ; Jolin, Hina A ; Huebner, Dirk ; Radford, John

The New England journal of medicine, 2018-01-25, Vol.378 (4), p.331-344 [Peer Reviewed Journal]

Full text available

Citations Cited by
5
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Material Type:
Article 		Add to e-Shelf

An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy

Tavaré, Richard ; Escuin-Ordinas, Helena ; Mok, Stephen ; McCracken, Melissa N ; Zettlitz, Kirstin A ; Salazar, Felix B ; Witte, Owen N ; Ribas, Antoni ; Wu, Anna M

Cancer research (Chicago, Ill.), 2016-01-01, Vol.76 (1), p.73-82 [Peer Reviewed Journal]

Full text available

Citations Cited by
6
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
Material Type:
Article 		Add to e-Shelf

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Stein, Eytan M ; Walter, Roland B ; Erba, Harry P ; Fathi, Amir T ; Advani, Anjali S ; Lancet, Jeffrey E ; Ravandi, Farhad ; Kovacsovics, Tibor ; DeAngelo, Daniel J ; Bixby, Dale ; Faderl, Stefan ; Jillella, Anand P ; Ho, Phoenix A ; O'Meara, Megan M ; Zhao, Baiteng ; Biddle-Snead, Charles ; Stein, Anthony S

Blood, 2018-01-25, Vol.131 (4), p.387-396 [Peer Reviewed Journal]

Full text available

Citations Cited by
7
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Material Type:
Article 		Add to e-Shelf

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, Alex F ; Moskowitz, Alison J ; Bartlett, Nancy L ; Vose, Julie M ; Ramchandren, Radhakrishnan ; Feldman, Tatyana A ; LaCasce, Ann S ; Ansell, Stephen M ; Moskowitz, Craig H ; Fenton, Keenan ; Ogden, Carol Anne ; Taft, David ; Zhang, Qu ; Kato, Kazunobu ; Campbell, Mary ; Advani, Ranjana H

Blood, 2018-03-15, Vol.131 (11), p.1183-1194 [Peer Reviewed Journal]

Full text available

Citations Cited by
8
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Material Type:
Article 		Add to e-Shelf

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

Younes, Anas ; Bartlett, Nancy L ; Leonard, John P ; Kennedy, Dana A ; Lynch, Carmel M ; Sievers, Eric L ; Forero-Torres, Andres

The New England journal of medicine, 2010-11-04, Vol.363 (19), p.1812-1821 [Peer Reviewed Journal]

Full text available

Citations Cited by
9
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Material Type:
Article 		Add to e-Shelf

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Modi, Shanu ; Saura, Cristina ; Yamashita, Toshinari ; Park, Yeon Hee ; Kim, Sung-Bae ; Tamura, Kenji ; Andre, Fabrice ; Iwata, Hiroji ; Ito, Yoshinori ; Tsurutani, Junji ; Sohn, Joohyuk ; Denduluri, Neelima ; Perrin, Christophe ; Aogi, Kenjiro ; Tokunaga, Eriko ; Im, Seock-Ah ; Lee, Caleb ; Lee, Keun Seok ; Hurvitz, Sara A ; Cortes, Javier ; Chen, Shuquan ; Zhang, Lin ; Shahidi, Javad ; Yver, Antoine ; Krop, Ian

The New England journal of medicine, 2020-02-13, Vol.382 (7), p.610-621 [Peer Reviewed Journal]

Full text available

Citations Cited by
10
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Material Type:
Article 		Add to e-Shelf

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Kim, Youn H ; Tavallaee, Mahkam ; Sundram, Uma ; Salva, Katrin A ; Wood, Gary S ; Li, Shufeng ; Rozati, Sima ; Nagpal, Seema ; Krathen, Michael ; Reddy, Sunil ; Hoppe, Richard T ; Nguyen-Lin, Annie ; Weng, Wen-Kai ; Armstrong, Randall ; Pulitzer, Melissa ; Advani, Ranjana H ; Horwitz, Steven M

Journal of clinical oncology, 2015-11-10, Vol.33 (32), p.3750-3758 [Peer Reviewed Journal]

Full text available

Citations Cited by

Results 1 - 10 of 777  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (678)

Refine My Results

Resource Type 

  1. Articles  (776)
  2. Books  (1)
  3. More options open sub menu

Creation Date 

From To
Refine
  1. Before 1997  (18)
  2. 1997 To 2001  (81)
  3. 2002 To 2005  (87)
  4. 2006 To 2012  (124)
  5. After 2012  (360)
  6. More options open sub menu

Language 

  1. English  (770)
  2. German  (5)
  3. French  (3)
  4. Japanese  (3)
  5. More options open sub menu

Searching Remote Databases, Please Wait